Radiant Innovation

Radiant Innovation Net Change in Cash

The Net Change in Cash of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -13.18 M TWD. In the previous year, Net Change in Cash was -27.95 M TWD — a change of -52.86% (higher).

Net Change in Cash

-13.18 MTWD

YoY

-52.86%

Last updated:

Net Change in Cash of Radiant Innovation is 2025 -13.18 M TWD. Net Change in Cash of Radiant Innovation was 2024 -27.95 M TWD. It decreases by -52.86% higher compared to the previous year.

The Radiant Innovation Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
8.07 M TWD
Jan 1, 2019
36.04 M TWD
Jan 1, 2020
585.27 M TWD
Jan 1, 2021
-511.76 M TWD
Jan 1, 2022
-98.09 M TWD
Jan 1, 2023
-21.39 M TWD
Jan 1, 2024
-27.95 M TWD
Jan 1, 2025
-13.18 M TWD
The Radiant Innovation Net Change in Cash history
YEARNet Change in CashYoY
-13.18 MTWD-52.86%
-27.95 MTWD+30.69%
-21.39 MTWD-78.20%
-98.09 MTWD-80.83%
-511.76 MTWD-187.44%
585.27 MTWD+1,523.77%
36.04 MTWD+346.75%
8.07 MTWD-118.01%
-44.80 MTWD+13.55%
-39.45 MTWD-50.16%
-79.17 MTWD-154.30%
145.81 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Net Change in Cash of Radiant Innovation is -13.18 M TWD in 2025.

Net Change in Cash of Radiant Innovation changed from -27.95 M TWD to -13.18 M TWD, representing a -52.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Radiant Innovation

All Key Metrics — Radiant Innovation